There may be a window shortly after menopause in which women can slow the development of clogged arteries through a method as simple as taking soy protein supplements.

The Fourth American Association of Cancer Research ( AACR ) Conference on The Science of Cancer Health Disparities is demonstrating that different races live with and survive cancers at very different rates. Acute leukemia is no exception.

Patients who have previously suffered from a blood vessel blockage and received a medication-coated stent to prop the artery open may have a lower risk of developing another blockage or having a heart attack.

Acute leukemias occur rapidly and are often extremely difficult to treat. Researchers have found that an existing cardiovascular medication may offer new treatment options.

Researchers have had success in identifying genetic errors that lead to a number of different types of cancers. This hasn't been the case with blood cancers, though - until now.

Some cancers respond well to chemotherapy in the beginning. After some time, though, the therapy may stop working because of a condition known as acquired drug resistance (ADR). Doctors are gaining ground in understanding why this resistance happens.

A parasite spread by deer ticks that can lead to a fatal malaria-like illness is becoming increasingly prevalent, causing concern over the safety of the U.S. blood supply.

For some patients, living with chronic myelogenous leukemia ( CML ) isn't terribly difficult; it just means taking a single pill once a day and living normal life.

For patients with coronary disease, taking medication to prevent blood clots for up to two years provides no additional benefit in avoiding adverse heart events as compared to taking it for six months.

Treatments are improving for heart attack patients with obstructed blood vessels. Newer technologies are both safer and more effective.